
(Amsterdam, Europe), — June 1st 2025 — Liberi Group and Starodub B.V. announce a consultancy agreement for mutual referral services. The agreement is effective as of May 1, 2025. This strategic collaboration reflects the commitment of both organizations to world-class expertise and innovation in life sciences and professional services.
What the Starodub consultancy agreement covers
Under the agreement, Liberi Group and Starodub B.V. will work closely together and combine their knowledge, networks, and operational strengths. As a result, they can create more value for clients and stakeholders of both organizations.
What both companies say about the agreement
“We are delighted to formalize our relationship with Starodub B.V. through this consultancy agreement,” said Frans Trouwen, Founder, CEO and Chairman of the Board of Liberi Group. “This partnership marks a significant milestone in our growth strategy, enabling us to broaden our reach and enhance the quality of services we offer.”
Valentyna Starodub, CEO of Starodub B.V., commented: “Our collaboration with the Liberi Group represents a powerful alignment of complementary strengths. While Liberi brings global expertise in business development, valuation, and investment services, Starodub adds deep regulatory, quality, manufacturing and product development know-how across pharmaceuticals and medical devices. Together, we offer biotech companies a uniquely integrated pathway— from early development and regulatory strategy to global market access and investor readiness.”
Focus of the Starodub consultancy agreement
Initially, the agreement focuses on joint referral consultancy initiatives across the global life sciences field. Liberi Group provides the Business Development Services and Valuation Services, while Starodub B.V. provides the Regulatory, Quality and Manufacturing Services. Moreover, both parties are already discussing opportunities for expanded collaboration.
About Liberi Group
Liberi Group is a global life sciences consultancy firm with subsidiaries in Europe and South Korea. It provides business development services, valuation services, and investment search for biotech companies.
About Starodub B.V.
Starodub B.V. is a consultancy guiding the development and approval of medicines and medical devices. Our experts support regulatory, quality, and manufacturing activities across small molecules, biologics, ATMPs, vaccines, devices, and software.
Media contacts
For media inquiries, please contact:
Frans Trouwen, Founder, CEO and Chairman of the Board of Liberi Group, FransTrouwen@LiberiGroup.com
Valentyna Starodub, founder and CEO of Starodub,
valentyna.starodub@starodub.nl

